Phospholipid-bound β2-glycoprotein I induces the production of anti-phospholipid antibodies

Journal of Autoimmunity

Volumn 15, Issue 1, 2000, Pages 21-32

  Subang, Rebecca ^a   Levine, Jerrold S ^b   Janoff, Andrew S ^c   Davidson, Sharon M K ^c   Taraschi, Theodore F ^d   Koike, Takao ^e   Minchey, Sharma R ^c   Whiteside, Melinda ^a   Tannenbaum, Marion ^a   Rauch, Joyce ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Liposome Company Incorporated   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anti cardiolipin antibodies; Anti phospholipid antibodies; Anti 2 glycoprotein I; Phospholipids; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; FATTY ACID; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTICOAGULATION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CIRCULAR DICHROISM; CONTROLLED STUDY; IMMUNOGENICITY; MEMBRANE VESICLE; MOUSE; NONHUMAN; OXIDATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0034458554     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0382     Document Type: Article

References (42)

1. Antiphospholipid antibodies and syndromes
2. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H)
3. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
4. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor
5. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon β2-glycoprotein I
6. Lipid asymmetry in membranes
7. Changes in membrane phospholipid distribution during platelet activation
8. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
9. Antiphospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a β2-glycoprotein I-dependent manner
10. Induction of anti-phospholipid autoantibodies by β2-glycoprotein I bound to apoptotic thymocytes
11. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles
12. Role of divalency in the high-affinity binding of anticardiolipin antibody-β2-glycoprotein I complexes to lipid membranes
13. Characterization of β2-glycoprotein I binding to phospholipid membranes
14. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein
15. Induction of anti-phospholipid autoantibodies by immunization with β2-glycoprotein I (apolipoprotein H)
16. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human β2-glycoprotein 1 or anticardiolipin antibodies alone
17. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice
18. Immunization of a rabbit with β2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipid and have similar reactivity as autoimmune anti-phospholipid antibodies
19. β2-Glycoprotein I. Molecular properties of an unusual apolipoprotein, apolipoprotein H
20. Effect of the carbohydrate moiety on the secondary structure of β2-glycoprotein I. Implications for the biosynthesis and folding of glycoproteins
21. Interactions and molecular structure of cardiolipin and β2-glycoprotein 1 (β2-GP-1)
22. β2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles
23. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and β2 glycoprotein 1 (and other proteins)
24. Association of blood proteins with large unilamellar liposomes in vivo
25. The phospholipid component of small unilamellar liposomes controls the rate of clearance of entrapped solutes from the circulation
26. Fate and behavior of liposomes in vivo: A review of controlling factors
27. The specificity of human anti-cytochrome c autoantibodies that arise in autoimmune disease
28. The mitochondrial generation of hydrogen peroxide: General properties and effect of hyperbaric oxygen
29. Are bacterial endotoxins involved in autoimmunity by CD5+ (Ly-1+) B cells?
30. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen
31. Antibodies to phospholipid-free β2-glycoprotein-I in patients with primary antiphospholipid syndrome
32. 'Anticardiolipin' autoantibodies recognize β2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding
33. Antiphospholipid antibodies require β2-glycoprotein I (apolipoprotein H) as cofactor
34. Changes in β2-glycoprotein I antigenicity induced by phospholipid binding
35. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
36. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems
37. Phosphorous assay in column chromatography
38. Phospholipid in the hexagonal phase is immunogenic: Evidence for immunorecognition of nonbilayer lipid phases in vivo
39. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids
40. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential
41. Solute distribution and trapping efficiencies observed in freeze-thawed multilamellar vesicles